Close
Nordic 9Nordic 9

XGEN Venture (investor - Venture Capital)

Italy xgenventure.com
See something wrong or missing? Let us know
Offices:Milano

XGEN Venture is an Italian investment company backing next generation life science ventures.

  • in 2024, XGEN Ventures announced raising €180 million for its debut fund
Average round investment:67.46M USD
Average number per year:2.0
Distribution: 2025 (2)2024 (3)2023 (1)
Portfolio companies: Italy AAVantgarde BioItaly NanophoriaItaly Genespire See the entire list
Mostly invests in: Italy Italy (4) Health services (6)
See the entire list

Showing 3 of 6 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

XGEN Venture mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to XGEN Venture

Name Criteria
Italy Generali Group
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Italy, Germany, Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Medicxi
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Japan Mitsubishi Corp
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Netherlands Flow ventures NL
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Luxembourg Alpha Intelligence Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Wilbe Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
United States New Science Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Netherlands Partners in Equity
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
France Famille C Venture
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Wearable, Manufacturing, Hardware, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Switzerland Korify Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany, Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top